PTC’s geographical footprint continues to expand as we fulfill our mission to provide access to best-in-class treatments for more patients around the world.
Our recent expansion into Kazakhstan is a further achievement in this mission. In the first quarter of 2023, PTC officially opened its affiliate office in Almaty and hired the first employees. Today, we leverage a dedicated cross functional team to support our operations and to serve our rare disease patients in the country.
The Republic of Kazakhstan is located in the central Asian part of Eastern Europe, also known as “Eurasia”. It is a unique country with 19 million inhabitants. While Kazakhstan has roughly the same population as Romania, Chile or the U.S. state of New York, it is physically the ninth largest country in the world. In recent years, Kazakhstan has become increasingly aware of rare diseases affecting the population and more proactive in collaborations with all stakeholders, including pharmaceutical industry, to provide disease awareness and treatment access to those in need.
Andrey Maximov, PTC’s General Manager for the Commonwealth of Independent States (CIS), which includes Kazakhstan, explains:
“Being here gives us great advantage to leverage our existing expertise, tap into local talent and to explore new opportunities with the aim of advancing access and care of patients with rare diseases. Although some progress in the management of rare diseases has been made in Kazakhstan in the last decade, we do know that patients and care providers still face problems with access to diagnosis and treatment. This is where we hope to make a difference and pioneer action of significance.”
Having a presence in Kazakhstan is also advantageous for cross border collaborations and to serve rare disease patients in surrounding Eurasian countries and regions.
“We have the potential to make a bigger impact in the entire region and accelerate care and treatment for more patients who are in need, “says Andrey.
Andrey and his team are very excited about the future for PTC in Kazakhstan. Equipped with abundant talent and resources, the team is well positioned to continue improving the lives of patients with rare diseases, their families and the community.
We have a company culture that invests in people. We have been successful so far because we empower our people to do their best work through a diverse, inclusive, and engaging work environment. That is our approach to success in Kazakhstan.